Fortune 40: Stock picks to retire on

Forty stock picks inspired by the greatest investors of all-time: From the deepest values to solid growth, these shares can make retirement dreams come true.

JNJ: The numbers
Market Cap $180.2 billion
Total Return YTD (June 11) -4.5%
Total Return Last 12 Months 4.0%
Earnings Growth (Next Five Years) 8.0%
P/E (Pasts 12 months) 15.8
P/E (Next Year's Estimate) 14.5
Dividend Yield 2.7%
Source: Baseline, as of June 11, 2007.
Growth and Income
Johnson & Johnson
Worries about drug-coated stents and competition from generic drugs have weighed on Johnson & Johnson. But its stock is still promising.

With medical devices, diagnostics, and consumer products, J&J is far more diversified than most pharmaceutical makers. In addition, it has increased its dividend for the past 44 years, generates a whopping $10 billion in free cash flow, and boasts an AAA credit rating.
Abbott Labs Johnson & Johnson Coca-Cola Altria Group Colgate General Mills Procter & Gamble Wyeth Accenture AIG Chubb ConocoPhillips McKesson 3M Microsoft United Health Pfizer Aetna Applied Industrial Carpenter Technology Loews Lufkin Tidewater VF Corp. Grey Wolf CSG Systems Hercules K-Swiss Navigant Consulting Park Electrochemical Penn Virginia Plexus UBS Diageo Novartis Petroleo Brasileiro Sanofi-Aventis Total Unilever Vodafone
Bargain hunting for condos The real estate slowdown has made parts of the Sunbelt a lot more affordable. Fortune presents a guide to finding the best deals in five markets. (more)
Retired at 50 Is it possible for someone who doesn't run a hedge fund or win the lottery to retire at 50 (or so)? Yes. (more)
Retirement: Now what?! Think you know what will make you happy? Learn from those who've been there, done that. (more)